Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone versus TIPS with variceal embolization

被引:43
作者
Gaba, Ron C. [1 ]
Bui, James T. [1 ]
Cotler, Scott J. [2 ]
Kallwitz, Eric R. [2 ]
Mengin, Olga T. [1 ]
Martinez, Brandon K. [1 ]
Berkes, Jaime L. [2 ]
Carrillo, Tami C. [1 ]
Knuttinen, M. Grace [1 ]
Owens, Charles A. [1 ]
机构
[1] Univ Illinois, Med Ctr Chicago, Dept Radiol, Intervent Radiol Sect, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Med, Hepatol Sect, Med Ctr Chicago, Chicago, IL 60612 USA
关键词
Transjugular intrahepatic portosystemic shunt (TIPS); Variceal hemorrhage; Embolization; Rebleeding; INTRAHEPATIC PORTOSYSTEMIC SHUNT; POLYTETRAFLUOROETHYLENE-COVERED STENT; PORTAL-HYPERTENSION; CREATION; MANAGEMENT; MULTICENTER; PREVENTION; EXPERIENCE; GRAFT;
D O I
10.1007/s12072-010-9206-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To compare rebleeding rates following treatment of variceal hemorrhage with TIPS alone versus TIPS with variceal embolization in the covered stent-graft era. In this retrospective study, 52 patients (M:F 29:23, median age 52 years) with hepatic cirrhosis and variceal hemorrhage underwent TIPS insertion between 2003 and 2008. Median Child-Pugh and MELD scores were 8.5 and 13.5. Generally, 10-mm diameter TIPS were created using covered stent-grafts (Viatorr; W.L. Gore and Associates, Flagstaff, AZ). A total of 37 patients underwent TIPS alone, while 15 patients underwent TIPS with variceal embolization. The rates of rebleeding and survival were compared. All TIPS were technically successful. Median portosystemic pressure gradient reductions were 13 versus 11 mmHg in the embolization and non-embolization groups. There were no statistically significant differences in Child-Pugh and MELD score, or portosystemic pressure gradients between each group. A trend toward increased rebleeding was present in the non-embolization group, where 8/37 (21.6%) patients rebled while 1/15 (6.7%) patients in the TIPS with embolization group rebled (P = 0.159) during median follow-up periods of 199 and 252 days (P = 0.374). Rebleeding approached statistical significance among patients with acute hemorrhage, where 8/32 (25%) versus 0/14 (0%) rebled in the non-embolization and embolization groups (P = 0.055). A trend toward increased bleeding-related mortality was seen in the non-embolization group (P = 0.120). TIPS alone showed a high incidence of rebleeding in this series, whereas TIPS with variceal embolization resulted in reduced recurrent hemorrhage. The efficacy of embolization during TIPS performed for variceal hemorrhage versus TIPS alone should be further compared with larger prospective randomized trials.
引用
收藏
页码:749 / 756
页数:8
相关论文
共 27 条
[1]  
ABIJAOUDEH N, 2008, J VASC INTERV RADIOL, V19, pS77
[2]   Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents [J].
Angermayr, B ;
Cejna, M ;
Koenig, F ;
Karnel, F ;
Hackl, F ;
Gangl, A ;
Peck-Radosavljevic, M .
HEPATOLOGY, 2003, 38 (04) :1043-1050
[3]   Prevention of recurrent variceal bleeding [J].
Berzigotti, A. ;
Garcia-Pagan, J. C. .
DIGESTIVE AND LIVER DISEASE, 2008, 40 (05) :337-342
[4]   American Association for the Study of Liver Diseases Practice Guidelines: The role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension [J].
Boyer, TD ;
Haskal, ZJ .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (05) :615-629
[5]   Transjugular intrahepatic portosystemic shunt in the management of complications of portal hypertension [J].
Boyer T.D. .
Current Gastroenterology Reports, 2008, 10 (1) :30-35
[6]   Predictors of early rebleeding and mortality after acute variceal hemorrhage in patients with cirrhosis [J].
Burroughs, Andrew K. ;
Triantos, Christos K. ;
O'Beirne, James ;
Patch, David .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (02) :72-73
[7]   Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation [J].
Charon, JPM ;
Alaeddin, FH ;
Pimpalwar, SA ;
Fay, DM ;
Olliff, SP ;
Jackson, RW ;
Edwards, RD ;
Robertson, IR ;
Rose, JD ;
Moss, JG .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2004, 15 (11) :1219-1230
[8]   FORMATION OF INTRAHEPATIC PORTOSYSTEMIC SHUNTS USING A BALLOON DILATATION CATHETER - PRELIMINARY CLINICAL-EXPERIENCE [J].
COLAPINTO, RF ;
STRONELL, RD ;
GILDINER, M ;
RITCHIE, AC ;
LANGER, B ;
TAYLOR, BR ;
BLENDIS, LM .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1983, 140 (04) :709-714
[9]   The role of transjugular lntrahepatic portosystemic shunt (TIPS) in the management of portal hypertension [J].
Colombato, Luis .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (10) :S344-S351
[10]   TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT STENOSIS AND REVISION - EARLY AND MIDTERM RESULTS [J].
HASKAL, ZJ ;
PENTECOST, MJ ;
SOULEN, MC ;
SHLANSKYGOLDBERG, RD ;
BAUM, RA ;
COPE, C .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 163 (02) :439-444